Vedanta’s BALCO Medical Centre observes World Cancer Day through awareness initiatives

6th February 2023

  • More than thirty thousand patients have benefitted from the accessible care provided by the hospital

Raipur; 6th February 2023: Vedanta’s BALCO Medical Centre (BMC), one of India’s leading cancer care hospitals, has undertaken a series of awareness initiatives on the occasion of World Cancer Day, to educate individuals on the cruciality of timely preventive screening and mitigation measures against various forms of cancer. In this regard, senior medical experts from BMC are reaching out to students, working professionals and other community members through several platforms such as awareness talks, health camps, and webinars.

The BALCO Medical Centre has emerged as a national leader in India’s oncology space with comprehensive facilities for medical, surgical, radiation, haematological, BMT and palliative care. A state-of-the-art, 170-bed ultra-modern, multi-modality diagnostic and therapeutic facility based in Raipur, Chhattisgarh, it has catered to the healthcare needs of more than thirty thousand patients since commencing operations in 2018. Along the way, it has established robust research and knowledge partnerships with leading institutions in this space, including the Tata Memorial Centre (TMC), Mumbai and Anuva, a transnational research company specialising in genomics biotech.

World Cancer Day is observed on 4th February annually to raise community awareness about cancer, improve education about the illness, and spark personal and organisational action towards mitigating its prevalence. It is also an occasion to reiterate its preventable nature through timely checks and share wider information on the treatment avenues available today.

Based on this year’s theme of “Close the Care Gap”, the BALCO Medical Centre organised ‘Prevention of Cancer’, a webinar featuring Dr. Mou Roy, Director, Surgical and Clinical Oncology, BMC who spoke on the various type of cancers prevalent today, their causal factors, and the screening and treatment options available. Further, a free cancer screening camp and a cancer awareness session was organised at the Lal Bahadur Shastri Civil Hospital in Bhilai, Chhattisgarh. Senior medical personnel from BMC led the initiative as resource persons. BMC is also conducting cancer awareness talks in nearly 20 schools, seeking to inform and empower over 9000 students and teachers throughout February.

Sharing the importance of such initiatives, Ms. Jyoti Agarwal, Chairperson, BALCO Medical Centre, said, “The BALCO Medical Centre seeks to create a paradigm shift in how people engage with cancer care, by encouraging a more proactive approach to maintaining health. With rapid advances made in the field of cancer care both globally and in India, we are within reach of a reality where cancer is no longer a threat. Through proactive awareness building sessions and knowledge partnerships, backed by quality healthcare accessible to all sections of society, the BALCO Medical Centre is continuously working towards realising this vision.”

Dr Bhawna Sirohi, Medical Director, BALCO Medical Centre, added, “World Cancer Day serves as a powerful reminder of the collective effort required to address the global challenge of cancer. The BALCO Medical Centre is pursuing the vision of a cancer-free future by making quality healthcare accessible to all. We have in place the quality talent and technology needed to tackle this in India. Our efforts are dedicated towards cancer awareness (tobacco cessation, menstrual hygiene, HPV vaccination), screening to make a paradigm shift in early diagnosis of cancers in India and prompt treatment for all irrespective of their socio-economic background. We pledge to close the care gap by doing the best for every single patient.”

BALCO Medical Centre is on a mission to help create a cancer-free society, dedicating its expertise and resources to address existing gaps in domestic cancer treatment, awareness, infrastructure and expertise. Set up under the aegis of the Vedanta Medical Research Foundation and backed by the Anil Agarwal Foundation, the institution is actively making a difference to the lives of lakhs of people through quality, accessible healthcare. It is one of the most preferred facilities in central India for advanced radiation therapy, brachytherapy, nuclear medicine, surgeries, chemotherapy, immunotherapy, blood-related disorders, plastic and reconstructive surgery, and pain & palliative care. Along with cancer treatment, all patients at BALCO Medical Centre also benefit from psychological, nutritional and physical therapy, as well as membership of various patient support groups for emotional support.

About Vedanta Limited:

Vedanta Limited, a subsidiary of Vedanta Resources Limited, is one of the world’s leading Oil & Gas and Metals company with significant operations in Oil & Gas, Zinc, Lead, Silver, Copper, Iron Ore, Steel, and Aluminium & Power across India, South Africa and Namibia. For two decades, Vedanta has been contributing significantly to nation building. Governance and sustainable development are at the core of Vedanta's strategy, with a strong focus on health, safety, and environment. Vedanta has put in place a comprehensive framework to be the ESG leader in the natural resources sector. Vedanta is committed to reducing carbon emissions to zero by 2050 or sooner and has pledged $5 billion over the next 10 years to accelerate the transition to net zero operations. Giving back is in the DNA of Vedanta, which is focused on enhancing the lives of local communities. The company’s flagship social impact program, Nand Ghars, have been set up as model anganwadis focused on eradicating child malnutrition, providing education, healthcare, and empowering women with skill development. Under the aegis of the Anil Agarwal Foundation, the umbrella entity for Vedanta’s social initiatives, the Vedanta group has pledged Rs 5000 crore over the next five years on social impact programmes with a thrust on nutrition, women & child development, healthcare, animal welfare, and grass-root level sports. Vedanta and the group companies have been featured in Dow Jones Sustainability Index, and was conferred Frost & Sullivan Sustainability Awards 2020, Golden Peacock Award for excellence in Corporate Governance 2022 and certified as a Great Place to Work 2022. Vedanta Limited is listed on the Bombay Stock Exchange and the National Stock Exchange.

For more information, please visit www.vedantalimited.com

About Vedanta Aluminium Business:

Vedanta Aluminium, a business of Vedanta Limited, is India’s largest producer of aluminium, manufacturing more than half of India’s aluminium i.e., 2.37 million tonnes in FY24. It is a leader in value-added aluminium products that find critical applications in core industries. Vedanta Aluminium ranks 1st in the S&P Global Corporate Sustainability Assessment 2023 world rankings for the aluminium industry, a reflection of its leading sustainable development practices. With its world-class aluminium smelters, alumina refinery and power plants in India, the company fulfils its mission of spurring emerging applications of aluminium as the ‘Metal of the Future’ for a greener tomorrow.

For more information, please log on to www.vedantaaluminium.com

Follow us on LinkedIN, Facebook, Twitter, Instagram

Disclaimer:

This press release contains “forward-looking statements” – that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance, and often contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “should” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. For us, uncertainties arise from the behaviour of financial and metals markets including the London Metal Exchange, fluctuations in interest and or exchange rates and metal prices; from future integration of acquired businesses; and from numerous other matters of national, regional, and global scale, including those of a political, economic, business, competitive or regulatory nature. These uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements.